Dr. Matthew Lorincz, MD

NPI: 1548350663
Total Payments
$36,085
2023 Payments
$19,538
Companies
3
Transactions
19
Medicare Patients
44
Medicare Billing
$3,688

Payment Breakdown by Category

Consulting$26,692 (74.0%)
Other$4,640 (12.9%)
Travel$4,364 (12.1%)
Food & Beverage$389.06 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $26,692 8 74.0%
Travel and Lodging $4,364 6 12.1%
Honoraria $3,125 1 8.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,515 1 4.2%
Food and Beverage $389.06 3 1.1%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $26,018 10 $0 (2023)
Novartis Pharmaceuticals Corporation $6,347 6 $0 (2019)
ORPHALAN INC $3,720 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $19,538 8 Alexion Pharmaceuticals, Inc. ($15,818)
2021 $5,610 4 Alexion Pharmaceuticals, Inc. ($5,610)
2020 $4,590 1 Alexion Pharmaceuticals, Inc. ($4,590)
2019 $6,347 6 Novartis Pharmaceuticals Corporation ($6,347)

All Payment Transactions

19 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/17/2023 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $5,610.00 General
04/24/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $2,148.41 General
04/24/2023 Alexion Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,515.00 General
04/24/2023 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $645.00 General
04/21/2023 ORPHALAN INC CUVRIOR (Drug) Honoraria Cash or cash equivalent $3,125.00 General
Category: Hepatology
04/21/2023 ORPHALAN INC CUVRIOR (Drug) Travel and Lodging Cash or cash equivalent $409.70 General
Category: Hepatology
04/21/2023 ORPHALAN INC CUVRIOR (Drug) Food and Beverage In-kind items and services $184.88 General
Category: Hepatology
02/17/2023 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $5,900.00 General
11/17/2021 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $892.50 General
10/13/2021 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,402.50 General
05/05/2021 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,020.00 General
04/14/2021 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,295.00 General
09/10/2020 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $4,590.00 General
11/19/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Consulting Fee Cash or cash equivalent $4,982.00 General
Category: NEUROSCIENCE
11/19/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Travel and Lodging Cash or cash equivalent $384.32 General
Category: NEUROSCIENCE
11/19/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Travel and Lodging In-kind items and services $335.46 General
Category: NEUROSCIENCE
11/19/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Food and Beverage Cash or cash equivalent $128.33 General
Category: NEUROSCIENCE
11/19/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Food and Beverage In-kind items and services $75.85 General
Category: NEUROSCIENCE
11/18/2019 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $441.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 22 22 $4,111 $2,061
2022 1 11 11 $1,338 $880.83
2021 1 11 11 $1,442 $746.29
Total Patients
44
Total Services
44
Medicare Billing
$3,688
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 11 11 $2,589 $1,194 46.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 11 11 $1,522 $867.13 57.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 11 11 $1,338 $880.83 65.8%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 11 11 $1,442 $746.29 51.8%

About Dr. Matthew Lorincz, MD

Dr. Matthew Lorincz, MD is a Neurology healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548350663.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Lorincz, MD has received a total of $36,085 in payments from pharmaceutical and medical device companies, with $19,538 received in 2023. These payments were reported across 19 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($26,692).

As a Medicare-enrolled provider, Lorincz has provided services to 44 Medicare beneficiaries, totaling 44 services with total Medicare billing of $3,688. Data is available for 3 years (2021–2023), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Ann Arbor, MI
  • Active Since 10/13/2006
  • Last Updated 03/09/2012
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1548350663

Products in Payments

  • AIMOVIG (Biological) $5,906
  • CUVRIOR (Drug) $3,720

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Ann Arbor